Found: 40
Select item for more details and to access through your institution.
Application of the Rotterdam postoperative cerebellar mutism syndrome prediction model in patients undergoing surgery for medulloblastoma in a single institution.
- Published in:
- Journal of Neurosurgery: Pediatrics, 2024, v. 33, n. 2, p. 174, doi. 10.3171/2023.9.PEDS23160
- By:
- Publication type:
- Article
Rare cases of medulloblastoma with hypermutation.
- Published in:
- Cancer Reports, 2022, v. 5, n. 5, p. 1, doi. 10.1002/cnr2.1521
- By:
- Publication type:
- Article
1 Ototoxicity and Cognitive Outcomes among Children Treated for Brain Tumors in Infancy.
- Published in:
- 2023
- By:
- Publication type:
- Abstract
Corrigendum: Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss.
- Published in:
- Nature Genetics, 2015, v. 47, n. 4, p. 423, doi. 10.1038/ng0415-423
- By:
- Publication type:
- Article
Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss.
- Published in:
- Nature Genetics, 2015, v. 47, n. 3, p. 263, doi. 10.1038/ng.3217
- By:
- Publication type:
- Article
Non-Malignant Cerebrospinal Fluid Ascites in a Patient with Atypical Teratoid Rhabdoid Tumor.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 4, p. 216, doi. 10.1159/000458441
- By:
- Publication type:
- Article
Current Landscape of NTRK Inhibition for Pediatric CNS Tumors.
- Published in:
- CNS Drugs, 2024, v. 38, n. 11, p. 841, doi. 10.1007/s40263-024-01121-z
- By:
- Publication type:
- Article
Intensive Interdisciplinary Rehabilitation in the Pediatric Hematology/Oncology Setting: Feasibility and Perceived Benefit of the Acute Neurological Injury Service.
- Published in:
- Cancers, 2024, v. 16, n. 17, p. 2999, doi. 10.3390/cancers16172999
- By:
- Publication type:
- Article
Concurrent ependymal and ganglionic differentiation in a subset of supratentorial neuroepithelial tumors with EWSR1-PLAGL1 rearrangement.
- Published in:
- Acta Neuropathologica Communications, 2024, v. 12, n. 1, p. 1, doi. 10.1186/s40478-024-01809-9
- By:
- Publication type:
- Article
A sellar presentation of a WNT-activated embryonal tumor: further evidence of an ectopic medulloblastoma.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Clinical features, neurologic recovery, and risk factors of postoperative posterior fossa syndrome and delayed recovery: a prospective study.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 9, p. 1586, doi. 10.1093/neuonc/noab030
- By:
- Publication type:
- Article
Phase II study of peginterferon alpha-2b for patients with unresectable or recurrent craniopharyngiomas: a Pediatric Brain Tumor Consortium report.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 11, p. 1696, doi. 10.1093/neuonc/noaa119
- By:
- Publication type:
- Article
Molecular grouping and outcomes of young children with newly diagnosed ependymoma treated on the multi-institutional SJYC07 trial.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 10, p. 1319, doi. 10.1093/neuonc/noz069
- By:
- Publication type:
- Article
The RACE to Develop New Targeted Therapies for Children With CNS Tumors.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 3, p. 434, doi. 10.1002/cpt.1937
- By:
- Publication type:
- Article
Development of Molecularly Targeted Therapies to Treat Pediatric Malignancies.
- Published in:
- Clinical Pharmacology & Therapeutics, 2017, v. 102, n. 5, p. 752, doi. 10.1002/cpt.785
- By:
- Publication type:
- Article
[11C]-Methionine PET for Identification of Pediatric High-Grade Glioma Recurrence.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.261891
- By:
- Publication type:
- Article
[11C]-Methionine PET for Identification of Pediatric High-Grade Glioma Recurrence.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.261891
- By:
- Publication type:
- Article
[11C]-Methionine PET for Identification of Pediatric High-Grade Glioma Recurrence.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.261891
- By:
- Publication type:
- Article
Outcomes for children with recurrent/refractory atypical teratoid rhabdoid tumor: A single‐institution study with molecular correlation.
- Published in:
- Pediatric Blood & Cancer, 2024, v. 71, n. 10, p. 1, doi. 10.1002/pbc.31208
- By:
- Publication type:
- Article
Phase 1 study of pomalidomide in children with recurrent, refractory, and progressive central nervous system tumors: A Pediatric Brain Tumor Consortium trial.
- Published in:
- Pediatric Blood & Cancer, 2021, v. 68, n. 2, p. 1, doi. 10.1002/pbc.28756
- By:
- Publication type:
- Article
FDG-PET CT in the evaluation of primary and secondary pancreatic malignancies.
- Published in:
- 2018
- By:
- Publication type:
- journal article
DNA-methylation subgroups carry no prognostic significance in ATRT-SHH patients in clinical trial cohorts.
- Published in:
- Acta Neuropathologica, 2023, v. 146, n. 3, p. 543, doi. 10.1007/s00401-023-02614-9
- By:
- Publication type:
- Article
WNT-activated embryonal tumors of the pineal region: ectopic medulloblastomas or a novel pineoblastoma subgroup?
- Published in:
- Acta Neuropathologica, 2020, v. 140, n. 4, p. 595, doi. 10.1007/s00401-020-02208-9
- By:
- Publication type:
- Article
Patient-derived orthotopic xenografts of pediatric brain tumors: a St. Jude resource.
- Published in:
- Acta Neuropathologica, 2020, v. 140, n. 2, p. 209, doi. 10.1007/s00401-020-02171-5
- By:
- Publication type:
- Article
Correction to: Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials.
- Published in:
- Acta Neuropathologica, 2020, v. 139, n. 2, p. 259, doi. 10.1007/s00401-019-02106-9
- By:
- Publication type:
- Article
Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes.
- Published in:
- Acta Neuropathologica, 2019, v. 138, n. 2, p. 309, doi. 10.1007/s00401-019-02020-0
- By:
- Publication type:
- Article
Advances in the classification of pediatric brain tumors through DNA methylation profiling: From research tool to frontline diagnostic.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Impact of tumor location on medulloblastoma subtyping and treatment (Commentary on teo et al., page xxx)
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Impact of tumor location on medulloblastoma subtyping and treatment (Commentary on teo et al., page xxx).
- Published in:
- Pediatric Blood & Cancer, 2013, v. 60, n. 9, p. 1393, doi. 10.1002/pbc.24549
- By:
- Publication type:
- Article
The posterior fossa syndrome questionnaire: using science to inform practice.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 157, n. 3, p. 465, doi. 10.1007/s11060-022-03990-0
- By:
- Publication type:
- Article
Evaluating pediatric spinal low-grade gliomas: a 30-year retrospective analysis.
- Published in:
- Journal of Neuro-Oncology, 2019, v. 145, n. 3, p. 519, doi. 10.1007/s11060-019-03319-4
- By:
- Publication type:
- Article
Computerized assessment of cognitive impairment among children undergoing radiation therapy for medulloblastoma.
- Published in:
- Journal of Neuro-Oncology, 2019, v. 141, n. 2, p. 403, doi. 10.1007/s11060-018-03046-2
- By:
- Publication type:
- Article
Comprehensive analysis of MYB/MYBL1-altered pediatric-type diffuse low-grade glioma.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 7, p. 1327, doi. 10.1093/neuonc/noae048
- By:
- Publication type:
- Article
Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG).
- Published in:
- Neuro-Oncology, 2022, v. 24, p. 1776, doi. 10.1093/neuonc/noac087
- By:
- Publication type:
- Article
Revised clinical and molecular risk strata define the incidence and pattern of failure in medulloblastoma following risk-adapted radiotherapy and dose-intensive chemotherapy: results from a phase III multi-institutional study.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 7, p. 1166, doi. 10.1093/neuonc/noab284
- By:
- Publication type:
- Article
Complete clinical regression of a BRAF V600Emutant pediatric glioblastoma multiforme after BRAF inhibitor therapy.
- Published in:
- 2014
- By:
- Publication type:
- Case Study
Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy.
- Published in:
- BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-258
- By:
- Publication type:
- Article
Medulloblastomics: the end of the beginning.
- Published in:
- Nature Reviews Cancer, 2012, v. 12, n. 12, p. 818, doi. 10.1038/nrc3410
- By:
- Publication type:
- Article
Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy.
- Published in:
- 2014
- By:
- Publication type:
- journal article